国际麻醉学与复苏杂志   2017, Issue (6): 3-3
    
右美托咪定对小儿先心病体外循环术中脑氧代谢及近远期认知功能的影响
韦天全, 刘国华, 贺全燕1()
1.广西科技大学附属柳州市妇幼保健院
Effects of dexmedetomidine on cerebral oxygen metabolism and postoperative cognitive function during cardiopulmonary bypass of CHD surgery
 全文:
摘要:

摘要 目的 探讨右美托咪定对小儿先心病体外循环术中脑氧代谢及近远期认知功能的影响 方法 将择期行体外循环下手术的先心病患儿84例,随机分为观察组和对照组各42例,观察组麻醉诱导后予以吸入2.5%七氟醚及右美托咪定0.7 μg• kg-1• h-1术中维持麻醉,而对照组麻醉诱导后予以吸入2.5%七氟醚维持麻醉, 分别在患儿体外循环开始前(T1)、升主动脉开放时(T2)、体外循环结束10min(T3) 以及手术后6h(T4)四个时间点采集3mL的桡动脉及静脉球部血样进行血气分析,计算颈内静脉血氧饱和度值(SjvO2)、动脉-颈内静 脉血氧含量差值 (Da-jvO2) 以及脑氧摄取率水平(CERO2),并在术前、术后3天、术后3个月、术后1年行简易智力状况调查(MMSE)评分。结果 两组患儿在T2时的SjvO2高于T1时,而Da-jvO2、CERO2低于T1时,差异有统计学意义(P<0.05),T2时观察组的SjvO2高于对照组,而Da-jvO2、CERO2低于对照组,差异有统计学意义(P<0.05),而T3、T4时两组患者的SjvO2 、Da-jvO2、CERO2的差异无统计学意义(P>0.05)。两组患儿在术前的MMSE评分差异无统计学意义(P>0.05),观察组术后4天和术后3月的MMSE评分分别为(26.53±1.54)分、(27.56±1.62)分,显著高于对照组的(24.34±1.26)分和(25.76±1.47)分,差异有统计学意义(P<0.05),但两组在术后1年的MMSE评分差异无统计学意义(P>0.05),结论 小儿先心病体外循环术中应用右美托咪定具有一定的脑保护作用,能改善脑氧代谢以及术后短期认知功能。

关键词: 右美托咪定;体外循环;氧代谢;认知功能
Abstract:

Abstreact objective To explore the effects of dexmedetomidine on cerebral oxygen metabolism and postoperative cognitive function during cardiopulmoary bypass of CHD surgery. Methods 84 childrens with cardiopulmonary bypass of CHD surgery were randomly divided into observation group and control group(n=42) . 2.5% sevoflurane and dexmedetomidine 0.7 μg• kg-1• h-1 was applied during maintenance of anesthesia, while the 2.5% sevoflurane was applied only in control group. At the time points of before cardiopulmonary bypass (T1), when the ascending aorta was open(T2), after cardiopulmonary bypass(T3) and 6 hours after operation (T4) blood from radial artery and right jugular bulb was harvested for blood gas analysis. The jugularn venous oxygensaturation(SjvO2), arterial venous oxygen contentdifference, (Da-jvO2) and cerebral extraction of oxygen (CERO2) were calculated according blood gas analysis, and mini-mental state examination( MMSE) score were evaluated before and 4 day, 3 month and 1 year after surgery. Results The SjvO2 of T2 was higher, but Da-jvO2 and CERO2 was lower than T1, and the differences were statistically significant(P<0.05). The SjvO2 in observation group was higher, but Da-jvO2 and CERO2 were lower than those in control group at T2, and the differences were statistically significant(P<0.05). There were no significant difference in SjvO2 、Da-jvO2、CERO2 at T3, T4 between two group(P>0.05). There were no significant difference in preoperative MMSE scores between two group(P>0.05). The MMSE scores in observation group at 4 day and 3 month after surgery were (26.53 + 1.54), (27.56 + 1.62), which was significantly higher than that in the control group (24.34 + 1.26) and (25.76 + 1.47), and the differences were statistically significant(P<0.05). But there were no significant difference in MMSE scores at 1 year after surgery between two group(P>0.05). Conclusion Dexmedetomidine could improve cerebral oxygen metabolism and postoperative cognitive function during cardiopulmonary bypass of CHD surgery.

Key words: Keywords Dexmedetomidine; Cardiopulmonary bypass; Oxygen metabolism; Cognitive function